Entity information:

There is no current or deferred income tax expense or benefit for the years ended December 31, 2016 and 2015. The provision for income taxes is different from that which would be obtained by applying the statutory federal income tax rate to income before income taxes. The items causing this difference are as follows:

 

    Year ended December 31,  
    2016     2015  
Tax (benefit) at U.S. statutory rate   $ (93,000 )   $ (525,000 )
Research and development credits     (82,000 )     -  
State income tax (benefit), net of federal benefit     (10,000 )     (56,000 )
Prior year true-up     247,400       -  
Other adjustments     (1,400 )     (16,000 )
Change in valuation allowance     (61,000 )     597,000  
    $ -     $ -  

 

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:

 

    December 31,  
    2016     2015  
Deferred tax assets, current:            
Allowance for doubtful accounts   $ 3,300     $ 3,100  
Stock warrant consideration and other     118,800       118,800  
Deferred revenue     -       49,800  
Valuation allowance     (122,100 )     (171,700 )
    $ -     $ -  

 

Deferred tax assets, noncurrent:            
Deferred revenue   $ -     $ 661,600  
Depreciation     27,300       25,700  
Accrued deferred compensation payable     575,900       493,800  
Research and development credit     216,900       134,900  
Stock compensation     105,800       105,300  
Net operating loss carryforward     9,879,100       9,395,100  
Valuation allowance     (10,805,000 )     (10,816,400 )
    $ -     $ -  

 

 
As of December 31, 2016 and 2015, the Company had federal and state net operating loss carry-forwards totaling approximately $26,300,000 and $24,700,000, respectively, which expire through 2036. The Company has established a valuation allowance to fully reserve all deferred tax assets at December 31, 2016 and 2015 because it is more likely than not that the Company will not be able to utilize these assets. The change in the valuation allowance for the years ended December 31, 2016 and 2015 was an increase of $61,000 and $597,000, respectively.

 

As of December 31, 2016, the Company has not performed an IRC Section 382 study to determine the amount, if any, of its net operating losses that may be limited as a result of the ownership change percentages during 2016. However, the Company will complete the study prior to the utilization of any of its recorded net operating losses.